|
HPLC测定非萘利酮片中非萘利酮的含量
|
Abstract:
目的:建立非萘利酮片中非萘利酮的含量测定。方法:色谱柱为和谱科学AceChrom AQ C18 (250 × 4.6 mm, 5 μm),流动相为甲醇-0.03 mol/L的醋酸铵水溶液(45:55),流速为1.0 mL/min,检测波长为255 nm,柱温为35℃。结论:非萘利酮浓度在2~100 mL/L范围内与峰面积呈良好的线性关系,相关系数R2 = 0.9998。本实验采用高效液相色谱法对非萘利酮的含量进行了研究,为其质量控制提供了快速、有效的分析手段。该方法准确可靠,操作简便易行,可作为非萘利酮片的质量控制方法。
Objective: To establish the determination of finerenone in finerenone tablets. Methods: The determination was performed on AceChrom AQ C18 column (250 × 4.6 mm, 5 μm) with mobile phase consisting of methanol-0.03 mol/L ammonium acetate aqueous solution (45:55) at the flow rate of 1.0 mL/min. The detection wavelength was 255 nm. The column temperature was 35?C. Conclusion: The concentration of finalidone in the range of 2~100 mg/L has a good linear relationship with the peak area, and the correlation coefficient R2 = 0.9998. High-performance liquid chromatography (HPLC) was used to study the content of finalidone, which provided a rapid and effective method for quality control. The method is accurate, reliable, easy to operate, and can be used as a quality control method for finalidone tablets.
[1] | 符灵智, 许剑峰, 马彦卓, 等. 盐皮质激素受体拮抗剂的研究进展[J]. 国际心血管病杂志, 2024, 51(2): 69-73. |
[2] | 周明双, 郑绍莹, 张雯, 等. 非奈利酮、钠-葡萄糖共转运蛋白-2抑制剂及两者联合应用对心肾保护作用的研究进展[J]. 临床心血管病杂志, 2024, 40(5): 416-421. |
[3] | 余万乾, 沈文, 杨萍萍, 等. 非奈利酮在心血管及相关疾病的研究进展[J]. 临床心血管病杂志, 2022, 38(11): 916-920. |
[4] | 黄坤, 廖玉华. 2023 ESC糖尿病合并心血管疾病管理指南解读[J]. 临床心血管病杂志, 2023, 39(10): 753-755. |
[5] | 李雯静, 杨小娟. 非奈利酮在糖尿病肾病中的应用进展[J]. 实用心脑肺血管病杂志, 2023, 31(7): 127-130. |
[6] | 颉晓铭, 刘永铭. 非奈利酮对2型糖尿病患者心肾保护作用的研究进展[J]. 实用药物与临床, 2024, 27(2): 145-150. |